Skip to content
Independent analysis of NHS open data
PharmaInsight

Metformin hydrochloride/rosiglitazone

Endocrine System Drugs used in diabetes BNF 0601023V0
Data updated April 2023 Download CSV
1items

Dispensed in April 2023

0items

Rolling 12 months

£4

Net ingredient cost · April 2023

Figure 1. Metformin hydrochloride/rosiglitazone: national items dispensed by month

0 1 2 Mar 2021 May 2021 May 2022 Jun 2022 Apr 2023 1 Mar 2021: 2 May 2021: 1 May 2022: 2 Jun 2022: 1 Apr 2023: 1

Source: NHSBSA Prescription Cost Analysis, to April 2023

Download CSV
Embed this chart

At a glance

  • Therapeutic class Drugs used in diabetes
  • Presentations 1 shown
  • Average cost / item £3.75
What this is
Net ingredient cost is the list price before discounts and dispensing fees, not what the NHS finally pays.

Top presentations, April 2023

The individual products dispensed under Metformin hydrochloride/rosiglitazone this month.

Presentations of Metformin hydrochloride/rosiglitazone, April 2023
Presentation BNF code Items Net ingredient cost
Avandamet 2mg/500mg tablets 0601023V0BBABAB 1 £4

Source: NHSBSA Prescription Cost Analysis · to April 2023 OGL v3.0

Where Metformin hydrochloride/rosiglitazone is dispensed

The regions and dispensing practices with the highest Metformin hydrochloride/rosiglitazone volumes.

Regional volumes from NHSBSA Prescription Cost Analysis; practice volumes from NHS dispensing data.

Compare Metformin hydrochloride/rosiglitazone with

Other medicines in the same BNF section, by prescribing volume.